1. Home
  2. BNR vs MYO Comparison

BNR vs MYO Comparison

Compare BNR & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • MYO
  • Stock Information
  • Founded
  • BNR 2014
  • MYO 2004
  • Country
  • BNR China
  • MYO United States
  • Employees
  • BNR N/A
  • MYO N/A
  • Industry
  • BNR Medical Specialities
  • MYO Industrial Specialties
  • Sector
  • BNR Health Care
  • MYO Health Care
  • Exchange
  • BNR Nasdaq
  • MYO Nasdaq
  • Market Cap
  • BNR 38.3M
  • MYO 44.6M
  • IPO Year
  • BNR 2020
  • MYO 2017
  • Fundamental
  • Price
  • BNR $7.91
  • MYO $1.05
  • Analyst Decision
  • BNR
  • MYO Strong Buy
  • Analyst Count
  • BNR 0
  • MYO 3
  • Target Price
  • BNR N/A
  • MYO $8.17
  • AVG Volume (30 Days)
  • BNR 44.7K
  • MYO 2.0M
  • Earning Date
  • BNR 09-12-2025
  • MYO 08-11-2025
  • Dividend Yield
  • BNR N/A
  • MYO N/A
  • EPS Growth
  • BNR N/A
  • MYO N/A
  • EPS
  • BNR N/A
  • MYO N/A
  • Revenue
  • BNR $72,112,038.00
  • MYO $40,760,091.00
  • Revenue This Year
  • BNR $136.32
  • MYO $25.69
  • Revenue Next Year
  • BNR N/A
  • MYO $23.52
  • P/E Ratio
  • BNR N/A
  • MYO N/A
  • Revenue Growth
  • BNR 0.53
  • MYO 93.08
  • 52 Week Low
  • BNR $2.18
  • MYO $0.92
  • 52 Week High
  • BNR $11.12
  • MYO $7.17
  • Technical
  • Relative Strength Index (RSI)
  • BNR 52.38
  • MYO 26.88
  • Support Level
  • BNR $8.29
  • MYO $1.01
  • Resistance Level
  • BNR $9.30
  • MYO $1.17
  • Average True Range (ATR)
  • BNR 1.03
  • MYO 0.09
  • MACD
  • BNR -0.16
  • MYO 0.02
  • Stochastic Oscillator
  • BNR 27.91
  • MYO 36.97

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Share on Social Networks: